Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
MiR-513a promotes human erythroid differentiation by modulating c-Jun.
Journal: FEBS open bio
Published: January 07, 2026
Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors.
Journal: Drug development research
Published: January 08, 2025
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitors.
Journal: European journal of medicinal chemistry
Published: October 28, 2024
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative.
Journal: Cancer chemotherapy and pharmacology
Published: February 24, 2023
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury.
Journal: iScience
Published: November 02, 2021
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology.
Journal: Frontiers in oncology
Published: October 05, 2021
Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells.
Journal: The Journal of thoracic and cardiovascular surgery
Published: October 01, 2020
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.
Journal: Blood advances
Published: September 16, 2020
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia.
Journal: Leukemia
Published: April 10, 2020
The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.
Journal: Development (Cambridge, England)
Published: February 19, 2019
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.
Journal: Advances in cancer research
Published: January 30, 2019
Last Updated: 09/26/2026